J.D. Rodgers
DuPont Merck Pharmaceutical Company
Wilmington
DE 19880-0500
USA
Name/email consistency: high
- Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. Rodgers, J.D., Lam, P.Y., Johnson, B.L., Wang, H., Li, R., Ru, Y., Ko, S.S., Seitz, S.P., Trainor, G.L., Anderson, P.S., Klabe, R.M., Bacheler, L.T., Cordova, B., Garber, S., Reid, C., Wright, M.R., Chang, C.H., Erickson-Viitanen, S. Chem. Biol. (1998)